ClinicalTrials.Veeva

Find clinical trials for Diabetes in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Taipei City, TWN:

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Active, not recruiting
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

Taipei, Taiwan and 45 other locations

study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participants with type 1 diabetes...

Active, not recruiting
Diabetes
Type 1 Diabetes
Drug: Insulin Degludec
Drug: Insulin Efsitora Alfa

Phase 3

Lilly
Lilly

Taipei City, Taipei, Taiwan and 76 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Taipei City, Taiwan and 89 other locations

with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (<16 cm2 vs ≥16 cm2 ) will ...

Enrolling
Diabetes Mellitus
Diabetic Foot Ulcer
Drug: ENERGI-F703 matched vehicle
Drug: ENERGI-F703 GEL

Phase 3

Energenesis Biomedical

Taipei, Taiwan and 20 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Taipei, Taiwan and 636 other locations

This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...

Enrolling
Diabetes Mellitus, Type 2
Drug: Placebo (semaglutide)
Drug: Oral semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 87 other locations

in people with peripheral arterial disease (PAD) and type 2 diabetes. Participants will either get semaglutide or placebo ("dummy") medicine...

Active, not recruiting
Diabetes Mellitus, Type 2
Peripheral Arterial Disease
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 124 other locations

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Part...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Taoyuan city, Taiwan and 467 other locations

in improving blood sugar control in participants with type 2 diabetes (T2D) with inadequate glycemic control using metformin. The study will...

Enrolling
Type 2 Diabetes
Drug: Dapagliflozin
Drug: Orforglipron

Phase 3

Lilly
Lilly

Taipei, Taiwan and 77 other locations

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Enrolling
Type 2 Diabetes
Overweight
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Taipei City, Taipei, Taiwan and 93 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems